Literature DB >> 27808412

Potassium currents in the heart: functional roles in repolarization, arrhythmia and therapeutics.

Nipavan Chiamvimonvat1,2, Ye Chen-Izu1,3,4, Colleen E Clancy3, Isabelle Deschenes5,6, Dobromir Dobrev7, Jordi Heijman8, Leighton Izu3, Zhilin Qu9, Crystal M Ripplinger3, Jamie I Vandenberg10, James N Weiss9, Gideon Koren11, Tamas Banyasz12, Eleonora Grandi3, Michael C Sanguinetti13, Donald M Bers3, Jeanne M Nerbonne14.   

Abstract

This is the second of the two White Papers from the fourth UC Davis Cardiovascular Symposium Systems Approach to Understanding Cardiac Excitation-Contraction Coupling and Arrhythmias (3-4 March 2016), a biennial event that brings together leading experts in different fields of cardiovascular research. The theme of the 2016 symposium was 'K+ channels and regulation', and the objectives of the conference were severalfold: (1) to identify current knowledge gaps; (2) to understand what may go wrong in the diseased heart and why; (3) to identify possible novel therapeutic targets; and (4) to further the development of systems biology approaches to decipher the molecular mechanisms and treatment of cardiac arrhythmias. The sessions of the Symposium focusing on the functional roles of the cardiac K+ channel in health and disease, as well as K+ channels as therapeutic targets, were contributed by Ye Chen-Izu, Gideon Koren, James Weiss, David Paterson, David Christini, Dobromir Dobrev, Jordi Heijman, Thomas O'Hara, Crystal Ripplinger, Zhilin Qu, Jamie Vandenberg, Colleen Clancy, Isabelle Deschenes, Leighton Izu, Tamas Banyasz, Andras Varro, Heike Wulff, Eleonora Grandi, Michael Sanguinetti, Donald Bers, Jeanne Nerbonne and Nipavan Chiamvimonvat as speakers and panel discussants. This article summarizes state-of-the-art knowledge and controversies on the functional roles of cardiac K+ channels in normal and diseased heart. We endeavour to integrate current knowledge at multiple scales, from the single cell to the whole organ levels, and from both experimental and computational studies.
© 2016 The Authors. The Journal of Physiology © 2016 The Physiological Society.

Entities:  

Keywords:  K channel blockers; atrial fibrillation; cardiac K channels; cardiac arrhythmia; cardiac repolarization; computational modeling; hERG channel; long QT syndrome

Mesh:

Substances:

Year:  2017        PMID: 27808412      PMCID: PMC5374105          DOI: 10.1113/JP272883

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  231 in total

Review 1.  Cardiac ultrarapid delayed rectifiers: a novel potassium current family o f functional similarity and molecular diversity.

Authors:  S Nattel; L Yue; Z Wang
Journal:  Cell Physiol Biochem       Date:  1999

2.  Rapid component I(Kr) of the guinea-pig cardiac delayed rectifier K(+) current is inhibited by beta(1)-adrenoreceptor activation, via cAMP/protein kinase A-dependent pathways.

Authors:  Christoph A Karle; Edgar Zitron; Wei Zhang; Sven Kathöfer; Wolfgang Schoels; Johann Kiehn
Journal:  Cardiovasc Res       Date:  2002-02-01       Impact factor: 10.787

3.  Mechanism of pacemaking in I(K1)-downregulated myocytes.

Authors:  Jonathan Silva; Yoram Rudy
Journal:  Circ Res       Date:  2003-02-21       Impact factor: 17.367

Review 4.  Myocardial potassium channels: electrophysiological and molecular diversity.

Authors:  D M Barry; J M Nerbonne
Journal:  Annu Rev Physiol       Date:  1996       Impact factor: 19.318

5.  Recapitulating long-QT syndrome using induced pluripotent stem cell technology.

Authors:  Ralf J Dirschinger; Alexander Goedel; Alessandra Moretti; Karl-Ludwig Laugwitz; Daniel Sinnecker
Journal:  Pediatr Cardiol       Date:  2012-03-13       Impact factor: 1.655

6.  Isoproterenol antagonizes prolongation of refractory period by the class III antiarrhythmic agent E-4031 in guinea pig myocytes. Mechanism of action.

Authors:  M C Sanguinetti; N K Jurkiewicz; A Scott; P K Siegl
Journal:  Circ Res       Date:  1991-01       Impact factor: 17.367

Review 7.  Calcium alternans in cardiac myocytes: order from disorder.

Authors:  Zhilin Qu; Michael Nivala; James N Weiss
Journal:  J Mol Cell Cardiol       Date:  2012-10-25       Impact factor: 5.000

Review 8.  Atrial selectivity of antiarrhythmic drugs.

Authors:  Ursula Ravens; Claire Poulet; Erich Wettwer; Michael Knaut
Journal:  J Physiol       Date:  2013-06-03       Impact factor: 5.182

Review 9.  hERG potassium channels and cardiac arrhythmia.

Authors:  Michael C Sanguinetti; Martin Tristani-Firouzi
Journal:  Nature       Date:  2006-03-23       Impact factor: 49.962

10.  Prediction of Thorough QT study results using action potential simulations based on ion channel screens.

Authors:  Gary R Mirams; Mark R Davies; Stephen J Brough; Matthew H Bridgland-Taylor; Yi Cui; David J Gavaghan; Najah Abi-Gerges
Journal:  J Pharmacol Toxicol Methods       Date:  2014-07-31       Impact factor: 1.950

View more
  36 in total

1.  Differential Expression and Remodeling of Transient Outward Potassium Currents in Human Left Ventricles.

Authors:  Eric K Johnson; Steven J Springer; Wei Wang; Edward J Dranoff; Yan Zhang; Evelyn M Kanter; Kathryn A Yamada; Jeanne M Nerbonne
Journal:  Circ Arrhythm Electrophysiol       Date:  2018-01

2.  K+ channels and cardiac electrophysiology.

Authors:  Donald M Bers; Ye Chen-Izu
Journal:  J Physiol       Date:  2017-04-01       Impact factor: 5.182

3.  The Pore-Lipid Interface: Role of Amino-Acid Determinants of Lipophilic Access by Ivabradine to the hERG1 Pore Domain.

Authors:  Laura Perissinotti; Jiqing Guo; Meruyert Kudaibergenova; James Lees-Miller; Marina Ol'khovich; Angelica Sharapova; German L Perlovich; Daniel A Muruve; Brenda Gerull; Sergei Yu Noskov; Henry J Duff
Journal:  Mol Pharmacol       Date:  2019-06-10       Impact factor: 4.436

Review 4.  Investigational antiarrhythmic agents: promising drugs in early clinical development.

Authors:  Jordi Heijman; Shokoufeh Ghezelbash; Dobromir Dobrev
Journal:  Expert Opin Investig Drugs       Date:  2017-07-20       Impact factor: 6.206

Review 5.  Calcium Signaling and Cardiac Arrhythmias.

Authors:  Andrew P Landstrom; Dobromir Dobrev; Xander H T Wehrens
Journal:  Circ Res       Date:  2017-06-09       Impact factor: 17.367

6.  Localization and functional consequences of a direct interaction between TRIOBP-1 and hERG proteins in the heart.

Authors:  David K Jones; Ashley C Johnson; Elon C Roti Roti; Fang Liu; Rebecca Uelmen; Rebecca A Ayers; Istvan Baczko; David J Tester; Michael J Ackerman; Matthew C Trudeau; Gail A Robertson
Journal:  J Cell Sci       Date:  2018-03-22       Impact factor: 5.285

7.  Chronic in vivo angiotensin II administration differentially modulates the slow delayed rectifier channels in atrial and ventricular myocytes.

Authors:  Dimitar P Zankov; Fadi N Salloum; Min Jiang; Gea-Ny Tseng
Journal:  Heart Rhythm       Date:  2018-08-01       Impact factor: 6.343

8.  Mutations in KCNK4 that Affect Gating Cause a Recognizable Neurodevelopmental Syndrome.

Authors:  Christiane K Bauer; Paolo Calligari; Francesca Clementina Radio; Viviana Caputo; Maria Lisa Dentici; Nadia Falah; Frances High; Francesca Pantaleoni; Sabina Barresi; Andrea Ciolfi; Simone Pizzi; Alessandro Bruselles; Richard Person; Sarah Richards; Megan T Cho; Daniela J Claps Sepulveda; Stefano Pro; Roberta Battini; Giuseppe Zampino; Maria Cristina Digilio; Gianfranco Bocchinfuso; Bruno Dallapiccola; Lorenzo Stella; Marco Tartaglia
Journal:  Am J Hum Genet       Date:  2018-10-04       Impact factor: 11.025

9.  MicroRNA 362-3p Reduces hERG-related Current and Inhibits Breast Cancer Cells Proliferation.

Authors:  Abdullah A Assiri; Noha Mourad; Minghai Shao; Patrick Kiel; Wanqing Liu; Todd C Skaar; Brian R Overholser
Journal:  Cancer Genomics Proteomics       Date:  2019 Nov-Dec       Impact factor: 4.069

Review 10.  Calcium Signaling in Cardiomyocyte Function.

Authors:  Guillaume Gilbert; Kateryna Demydenko; Eef Dries; Rosa Doñate Puertas; Xin Jin; Karin Sipido; H Llewelyn Roderick
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-03-02       Impact factor: 10.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.